跳至主要内容
临床试验/ACTRN12609000040268
ACTRN12609000040268已完成未知

A study to determine the ability of plasma B-type Natriuretic Peptide signal peptide (BNP-SP) concentrations to act as a specific and early clinical biomarker of Acute Myocardial Infarction in patients with chest pain.

Health Research Council of New Zealand0 个研究点目标入组 80 人开始时间: 2009年1月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 50 males or females
  • 18 years of age or older
  • Admitted to the coronary care unit of Christchurch Hospital with typical chest pains (<4 hours from onset), clear evidence of ST segment elevation on Electrocardiograph together with a rise and fall of plasma Troponin levels
  • 10 patients with chronic renal failure on maintenance haemodialysis
  • 5 patients with hypothyroidism and 5 patients with thyrotoxicosis
  • 10 patients presenting to the emergency department with acute heart failure not secondary to Acute Myocardial Infarction

排除标准

  • Unable to give informed consent
  • Unable to comply with study requirements

研究者

相似试验